Viridian Therapeutics, Inc. Share Price
VRDNViridian Therapeutics, Inc. Stock Performance
Open $28.64 | Prev. Close $28.71 | Circuit Range N/A |
Day Range $28.23 - $28.98 | Year Range $9.90 - $28.98 | Volume 92,747 |
Average Traded $28.62 |
Viridian Therapeutics, Inc. Share Price Chart
About Viridian Therapeutics, Inc.
Viridian Therapeutics, Inc. engages in discovering, developing, and commercializing treatments for serious and rare diseases. The company's product pipeline includes veligrotug, a monoclonal antibody targeting insulin-like growth factor-1 receptor that is in Phase 3 clinical trial for the treatment of thyroid eye disease (TED); and VRDN-003, a next generation IGF-1R monoclonal antibodies targeting IGF-1R and engineered of half-life extension technology, which is in Phase 3 clinical trial for the treatment of TED. It also develops portfolio of engineered anti-neonatal Fc receptor inhibitors, such as VRDN-006 and VRDN-008 for autoimmune disease. The company was formerly known as Miragen Therapeutics, Inc. and changed its name to Viridian Therapeutics, Inc. in January 2021.Viridian Therapeutics, Inc. was founded in 2010 and is headquartered in Waltham, Massachusetts.
Viridian Therapeutics, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
12-Nov-25 | $28.64 | $28.92 | +0.00% |
12-Nov-25 | $28.64 | $28.92 | +1.80% |
11-Nov-25 | $27.48 | $28.41 | +2.77% |
10-Nov-25 | $27.43 | $27.64 | +0.71% |
07-Nov-25 | $27.36 | $27.45 | -0.25% |
06-Nov-25 | $25.13 | $27.52 | +12.67% |
05-Nov-25 | $23.04 | $24.43 | +8.24% |
FAQs on Viridian Therapeutics, Inc. Share Price
Can I buy Viridian Therapeutics, Inc. shares in India?
What is the share price of Viridian Therapeutics, Inc.?
What is the 5 year returns of Viridian Therapeutics, Inc.?
What are the high & low stock price of Viridian Therapeutics, Inc. today?
What is the 52-week high and low of Viridian Therapeutics, Inc. stock?